Cork2021 wrote: » Basically his contact in Pfizer has said safety data will be released next week and that it is safe and expects EUA from both the fda and ema not long after possibly the first week in December. Reckons similar time line for the moderna vaccine. Didn’t mention anything else. One comment he did make from hopefully by summer 21 we’ll be able to nearly fully relax, also said even if restrictions end there will be a lot of hesitant people and we probably won’t see full stadiums or gigs. Oh and needs at least 70% uptake of the vaccines to bring R0 to near 0.2
stephenjmcd wrote: » Can understand people being hesitant at first to go back to a stadium or gig for example. Like everything though slowly people become more comfortable again. In terms of vaccine, Pfizer had said they expected safety data around next week, good that Moderna doesn't seem to be too far behind either. Looking good to potentially have 3 with EUA for January
Cork2021 wrote: » Oh and needs at least 70% uptake of the vaccines to bring R0 to near 0.2
iguana wrote: » I've been wondering about the 70% figure. Is that of total population including children? As far as I'm aware at this point only Pfizer/Biontech have tested on children and that's only in the 12-18 age range. So if the vaccine won't be given to pre-pubescent children for quite some time, does that mean we need a much higher proportion of adults to take the vaccine to bring us to 70%?
Water John wrote: » The famous herd immunity, now it becomes a real factor to be considered with vaccines. I see the 70% but I think I've seen, in relation to other vaccines like 90%. Would that work out then as 70% uptake multiplied by 90% efficacy, resulting in a true immunity in the population of 63%? Whilst 90% by 90% would give 81% population immunity.
timsey tiger wrote: » The inate infectivity of the virus also has to be considered. A virus like measles is super infectious(R0 between 12 and 18), so you need a super high level of immunity (>90%) to stop it spreading through the population. Covid 19 is not in that league at all so a far lower level of immunity is required to suppress it.
Water John wrote: » Luke said there's five more following those, so eight by the summer.
Water John wrote: » It was good luck that MERS had a low infectivity as it had a 33% mortality. In ways we missed a bullet. Covid 19 could have been a lot worse.
funnydoggy wrote: » Am I right in thinking now since the mRNA vaccine seems to be working so well, that scientists can now create a successful MERS vaccine with this tech?
hmmm wrote: » I guess so, that also uses a spike protein. The trouble with something like MERS is so few people get it, the cost of phase 1-3 trials are prohibitive. I don't think the big countries will allow themselves to get caught out like with Covid again - imagine if this had a 20% fatality rate. I'd say we'll see a few mRNA plants being built which will stand semi-idle unless needed to rapidly build vaccines for new emerging viruses.
Thelonious Monk wrote: » Avian flu now spreading in Belgium. Factory farming and cheap meat and our diets need to change.
daydorunrun wrote: » I always thought because MERS had a high mortality rate it burned out by killing its host too quickly?
begbysback wrote: » Don’t worry, I never take financial advice from someone who can’t spell anonymous
ShineOn7 wrote: » Whatever happened to the Russia vaccine? After the initial announcement I've seen nothing popping up in the media Another "we're better than America" lie from Putin?
Marhay70 wrote: » News emerging this morning from the UK that authorities are considering taking action against social media companies which fail to remove anti-vax material from their outlets. I agree there is no place for it in a thread like this but I wonder if such a move could prove counter productive. I can just hear the narrative now, e.g. "What's to hide ?etc."
Voltex wrote: » Sputnik V data looking really good too. Not sure how they work out 92% efficacy out of 20 confirmed cases though.https://sputnikvaccine.com/newsroom/pressreleases/the-first-interim-data-analysis-of-the-sputnik-v-vaccine-against-covid-19-phase-iii-clinical-trials-/
![Photo of [Deleted User]](https://wc.vanillicon.com/v2/c8f64116a02fb35bb4652b6f11c7f3cf.svg)
